Groundbreaking Dual-Target Alzheimer's vaccine enters human testing
Prevention
Not yet recruiting
This early-stage study will test the safety of an experimental Alzheimer's vaccine called DUVAX in 24 healthy adults aged 40-65. Participants will receive either the vaccine or a placebo injection to see how well it's tolerated and whether it triggers an immune response against A…
Phase: PHASE1 • Sponsor: Nuravax, Inc. • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC